CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 1

Incompliant submissions 0

Total trials 1

My Organizations' Clinical Trials

Showing 100 of 3173 entries

View as:

A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults

Phase: N/A Priority: Normal

NCT ID: NCT00855101 Org: User:

Start: 04/30/09 End: 07/31/09 Due: 07/31/10

Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01247896 Org: User:

Start: 12/31/10 End: 06/30/11 Due: 06/30/12

A GBT021601 ADME Microtracer Study in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT05718687 Org: User:

Start: 12/22/22 End: 08/10/23 Due: 08/10/24

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT01458951 Org: User:

Start: 06/30/12 End: 06/30/15 Due: 06/30/16

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Phase: N/A Priority: Normal

NCT ID: NCT01712074 Org: User:

Start: 11/30/12 End: 09/30/15 Due: 09/30/16

Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.

Phase: N/A Priority: Normal

NCT ID: NCT06025227 Org: User:

Start: - End: - Due: -

Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00348374 Org: User:

Start: 06/30/06 End: 08/31/08 Due: 08/31/09

Open-Label Extension of Voxelotor

Phase: N/A Priority: Normal

NCT ID: NCT04188509 Org: User:

Start: 11/18/19 End: 11/01/24 Due: 11/01/25

Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

Phase: N/A Priority: Normal

NCT ID: NCT01260311 Org: User:

Start: 02/28/11 End: 10/31/13 Due: 10/31/14

A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

Phase: N/A Priority: Normal

NCT ID: NCT01740427 Org: User:

Start: 02/22/13 End: 11/09/23 Due: 11/09/24

A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults

Phase: N/A Priority: Normal

NCT ID: NCT06646042 Org: User:

Start: 10/28/24 End: 01/17/25 Due: 01/17/26

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Phase: N/A Priority: Normal

NCT ID: NCT06105632 Org: User:

Start: 01/09/24 End: 01/21/28 Due: 01/21/29

A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01097876 Org: User:

Start: 04/30/10 End: 07/31/10 Due: 07/31/11

A Phase 1 Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01396135 Org: User:

Start: 08/26/11 End: 10/29/11 Due: 10/29/12

Cumulative Irritation Test

Phase: N/A Priority: Normal

NCT ID: NCT00781664 Org: User:

Start: 10/31/08 End: 11/30/08 Due: 11/30/09

Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC

Phase: N/A Priority: Normal

NCT ID: NCT00313768 Org: User:

Start: 12/31/05 End: 05/31/08 Due: 05/31/09

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Phase: N/A Priority: Normal

NCT ID: NCT02740413 Org: User:

Start: 01/11/16 End: 12/31/17 Due: 12/31/18

Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT01432249 Org: User:

Start: 03/31/13 End: 09/30/13 Due: 09/30/14

Long Term Safety Observation of Crizotinib in Chinese NSCLC Population

Phase: N/A Priority: Normal

NCT ID: NCT03672643 Org: User:

Start: 01/28/19 End: 09/28/23 Due: 09/28/24

A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248

Phase: N/A Priority: Normal

NCT ID: NCT00094029 Org: User:

Start: 09/30/04 End: 10/31/11 Due: 10/31/12

First In Human Study Of Increasing Oral Doses Of PF-04634817

Phase: N/A Priority: Normal

NCT ID: NCT01098877 Org: User:

Start: 04/30/10 End: 09/30/10 Due: 09/30/11

Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir

Phase: N/A Priority: Normal

NCT ID: NCT04962230 Org: User:

Start: 07/15/21 End: 10/09/21 Due: 10/09/22

Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age

Phase: N/A Priority: Normal

NCT ID: NCT01897753 Org: User:

Start: 03/31/12 End: 09/30/13 Due: 09/30/14

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00424411 Org: User:

Start: 09/30/99 End: 12/31/00 Due: 12/31/01

A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

Phase: N/A Priority: Normal

NCT ID: NCT04832139 Org: User:

Start: 03/30/21 End: 11/22/21 Due: 11/22/22

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults	NCT00855101	Pfizer	user2@example.com	None	2009-04-30	2009-07-31	2010-07-31	-	-	2025-07-14
Single Dose Escalation Study of PF-05190457 in Healthy Volunteers	NCT01247896	Pfizer	user2@example.com	None	2010-12-31	2011-06-30	2012-06-30	-	-	2025-07-14
A GBT021601 ADME Microtracer Study in Healthy Volunteers	NCT05718687	Pfizer	user2@example.com	None	2022-12-22	2023-08-10	2024-08-10	-	-	2025-07-14
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis	NCT01458951	Pfizer	user2@example.com	None	2012-06-30	2015-06-30	2016-06-30	-	-	2025-07-14
Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil	NCT01712074	Pfizer	user2@example.com	None	2012-11-30	2015-09-30	2016-09-30	-	-	2025-07-14
Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.	NCT06025227	Pfizer	user2@example.com	None	-	-	-	-	-	2025-07-14
Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes	NCT00348374	Pfizer	user2@example.com	None	2006-06-30	2008-08-31	2009-08-31	-	-	2025-07-14
Open-Label Extension of Voxelotor	NCT04188509	Pfizer	user2@example.com	None	2019-11-18	2024-11-01	2025-11-01	-	-	2025-07-14
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder	NCT01260311	Pfizer	user2@example.com	None	2011-02-28	2013-10-31	2014-10-31	-	-	2025-07-14
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)	NCT01740427	Pfizer	user2@example.com	None	2013-02-22	2023-11-09	2024-11-09	-	-	2025-07-14
A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults	NCT06646042	Pfizer	user2@example.com	None	2024-10-28	2025-01-17	2026-01-17	-	-	2025-07-14
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment	NCT06105632	Pfizer	user2@example.com	None	2024-01-09	2028-01-21	2029-01-21	-	-	2025-07-14
A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer Subjects	NCT01097876	Pfizer	user2@example.com	None	2010-04-30	2010-07-31	2011-07-31	-	-	2025-07-14
A Phase 1 Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese Subjects	NCT01396135	Pfizer	user2@example.com	None	2011-08-26	2011-10-29	2012-10-29	-	-	2025-07-14
Cumulative Irritation Test	NCT00781664	Pfizer	user2@example.com	None	2008-10-31	2008-11-30	2009-11-30	-	-	2025-07-14
Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC	NCT00313768	Pfizer	user2@example.com	None	2005-12-31	2008-05-31	2009-05-31	-	-	2025-07-14
Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study	NCT02740413	Pfizer	user2@example.com	None	2016-01-11	2017-12-31	2018-12-31	-	-	2025-07-14
Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis	NCT01432249	Pfizer	user2@example.com	None	2013-03-31	2013-09-30	2014-09-30	-	-	2025-07-14
Long Term Safety Observation of Crizotinib in Chinese NSCLC Population	NCT03672643	Pfizer	user2@example.com	None	2019-01-28	2023-09-28	2024-09-28	-	-	2025-07-14
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248	NCT00094029	Pfizer	user2@example.com	None	2004-09-30	2011-10-31	2012-10-31	-	-	2025-07-14
First In Human Study Of Increasing Oral Doses Of PF-04634817	NCT01098877	Pfizer	user2@example.com	None	2010-04-30	2010-09-30	2011-09-30	-	-	2025-07-14
Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir	NCT04962230	Pfizer	user2@example.com	None	2021-07-15	2021-10-09	2022-10-09	-	-	2025-07-14
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age	NCT01897753	Pfizer	user2@example.com	None	2012-03-31	2013-09-30	2014-09-30	-	-	2025-07-14
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes	NCT00424411	Pfizer	user2@example.com	None	1999-09-30	2000-12-31	2001-12-31	-	-	2025-07-14
A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device	NCT04832139	Pfizer	user2@example.com	None	2021-03-30	2021-11-22	2022-11-22	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance